Healthstream (HSTM) Cost of Revenue (2010 - 2026)

Healthstream (HSTM) has 17 years of Cost of Revenue data on file, last reported at $27.8 million in Q1 2026.

• On a quarterly basis, Cost of Revenue rose 8.91% year-over-year to $27.8 million in Q1 2026; TTM through Mar 2026 was $109.5 million, a 10.8% increase from a year earlier, with the FY2025 full-year figure at $107.2 million, up 9.47% from the prior year.
• Cost of Revenue for Q1 2026 stood at $27.8 million, down from $28.9 million in the prior quarter.
• Over the last five years, Cost of Revenue for HSTM reached as high as $28.9 million in Q4 2025 and fell as low as $22.0 million in Q1 2022.
• Historically, Cost of Revenue has averaged $24.7 million across 5 years, with a median of $24.0 million in 2023.
• Across the five-year window, Cost of Revenue dropped 3.3% in 2022 and rose 14.9% in 2025, its largest moves.
• Year by year, Cost of Revenue stood at $23.5 million in 2022, then advanced by 2.01% to $24.0 million in 2023, then grew by 4.58% to $25.1 million in 2024, then advanced by 14.9% to $28.9 million in 2025, then declined by 3.79% to $27.8 million in 2026.
• Per Business Quant data, the three most recent Cost of Revenue figures were $27.8 million in Q1 2026, $28.9 million in Q4 2025, and $26.5 million in Q3 2025.